[HIV susceptibility determination: a qualified position against regarding a complex technology].
作者信息
Telenti A
机构信息
División de Enfermedades Infecciosas, Hospital Universitario de Vaud. Lausana, Suiza.
出版信息
Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):45-6.
PMID:11428060
Abstract
摘要
相似文献
1
[HIV susceptibility determination: a qualified position against regarding a complex technology].
Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):45-6.
2
[GESIDA Consensus document on the use of resistance studies in clinical practice].
Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):53-60.
3
How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
IAPAC Mon. 2001 Mar;7(3):85-90.
4
Putting resistance to the test.
Posit Living. 2001 Apr;10(3):15-6, 43-6.
5
[Incorporation of the test of resistance to antiretroviral drugs in clinical practice].
Med Clin (Barc). 1999 Mar 27;112(11):412-5.
6
[Primary resistance to antiretroviral agents].
Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):22-5.
7
HIV drug resistance testing: an update for the clinician.
AIDS Clin Care. 2001 Oct;13(10):89-91, 94-6, 100.
8
Viro diversity (or, keeping up with HIV's evolutionary caprice).
IAPAC Mon. 2001 Jul;7(7):198-207.
9
[Drug resistance in antiretroviral therapy of HIV infection].
Med Klin (Munich). 2003 Dec 15;98(12):692-9. doi: 10.1007/s00063-003-1315-4.
10
HIV resistance testing benefit is shown.
AIDS Alert. 2001 Oct;16(10):136.
Zotero 插件